Key result
Remimazolam demonstrated a clear advantage over propofol for anesthetic induction, resulting in a lower incidence of intraoperative hypotension and reduced need for vasoactive drugs across various surgical procedures.
Why the study?
Propofol frequently induces intraoperative hypotension, whereas remimazolam may have fewer hemodynamic side effects, motivating a comparison of their hypotensive effects during anesthetic induction across various surgeries.
Does remimazolam reduce intraoperative hypotension compared to propofol in patients undergoing anesthetic induction?
Systematic Review (n=6,293)
Does remimazolam reduce intraoperative hypotension compared to propofol in patients undergoing anesthetic induction?
Remimazolam provides greater hemodynamic stability and a lower incidence of intraoperative hypotension compared to propofol during anesthetic induction across various surgical procedures.
Answers are grounded in this paper and cite their sources.
Supports remimazolam preference for induction to limit hypotension; confirms hemodynamic superiority over propofol in Level 1 evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Resende et al. (2023) conducted a systematic review in Intraoperative hypotension during anesthetic induction (n=6,293). Remimazolam vs. Propofol was evaluated on Incidence of intraoperative hypotension. Remimazolam demonstrated a clear advantage over propofol for anesthetic induction, resulting in a lower incidence of intraoperative hypotension and reduced need for vasoactive drugs across various surgical procedures.
Synapse has enriched 10 related papers. Consider them for comparative context: